XML 34 R25.htm IDEA: XBRL DOCUMENT v3.23.2
Restatement (Tables)
6 Months Ended
Jun. 30, 2023
Accounting Changes and Error Corrections [Abstract]  
Schedule of Error Corrections and Prior Period Adjustments
Description of Restatement of Financial Information
In the following tables, we have presented a reconciliation of our unaudited condensed consolidated financial information as originally reported, to the as restated amounts as of and for the three and six months ended June 30, 2022. The restatement for the three and nine months ended September 30, 2022 will be effected in the future filing of our 2023 unaudited condensed consolidated financial statements within our Quarterly Report on Form 10-Q.
The table below sets forth the unaudited condensed consolidated balance sheet information, including the balances as reported, adjustments and the balances as restated (in thousands, except per share amounts):
June 30, 2022
As ReportedAdjustmentsAs Restated
Assets
Current assets:
Cash and cash equivalents
$215,537 $— $215,537 
Accounts receivable, net of allowances of $4,508
12,993 — 12,993 
Prepaid expenses and other current assets
13,860 — 13,860 
Total current assets
242,390 — 242,390 
Property and equipment, net
49,342 — 49,342 
June 30, 2022
As ReportedAdjustmentsAs Restated
Goodwill
59,933 — 59,933 
Intangible assets, net
14,570 — 14,570 
Operating lease right-of-use assets
6,961 — 6,961 
Deferred income taxes
25,685 4,064 29,749 
Available-for-sale debt securities
1,182 — 1,182 
Other assets
13,319 (7)13,312 
Total assets
$413,382 $4,057 $417,439 
Liabilities and stockholders’ equity
Current liabilities:
Accounts payable
18,404 — 18,404 
Accrued expenses and other current liabilities55,820 (1,235)54,585 
Deferred revenue
163,140 — 163,140 
Operating lease liabilities
1,542 — 1,542 
Total current liabilities
238,906 (1,235)237,671 
Operating lease liabilities, non-current
4,842 — 4,842 
Deferred revenue
1,137 — 1,137 
Other liabilities
2,841 — 2,841 
Total liabilities
247,726 (1,235)246,491 
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $0.001 par value; 100,000 shares authorized; 0 issued or outstanding at June 30, 2022
— — — 
Common stock, $0.001 par value; 1,000,000 shares authorized; 196,079 shares issued and outstanding at June 30, 2022
196 — 196 
Additional paid-in capital
994,558 — 994,558 
Accumulated deficit
(830,952)5,292 (825,660)
Accumulated other comprehensive income
1,854 — 1,854 
Total stockholders’ equity
165,656 5,292 170,948 
Total liabilities and stockholders’ equity
$413,382 $4,057 $417,439 
The table below sets forth the unaudited condensed consolidated statements of operations, including the balances as reported, adjustments and the as restated balances (in thousands, except per share amounts):
Three Months EndedSix Months Ended
June 30, 2022June 30, 2022
As ReportedAdjustmentsAs RestatedAs reportedAdjustmentsAs restated
Revenue
$163,867 $(1,218)$162,649 $318,076 $— $318,076
Cost of revenue57,393 (242)57,151 113,333 — 113,333 
Gross profit
106,474 (976)105,498 204,743 — 204,743 
Operating expenses:
Sales and marketing72,945 (1,224)71,721 149,819 (1,224)148,595 
Technology and development
16,197 — 16,197 34,156 34,156
General and administrative
28,969 — 28,969 58,457 — 58,457 
Total operating expenses
118,111 (1,224)116,887 242,432 (1,224)241,208 
Loss from operations
(11,637)248 (11,389)(37,689)1,224 (36,465)
Interest income (expense), net
29 — 29 (24)— (24)
Other expense, net
(2,022)— (2,022)(3,566)— (3,566)
Loss before income taxes
(13,630)248 (13,382)(41,279)1,224 (40,055)
Three Months EndedSix Months Ended
June 30, 2022June 30, 2022
As ReportedAdjustmentsAs RestatedAs reportedAdjustmentsAs restated
(Benefit from) provision for income taxes
(451)(188)(639)2,509 (4,068)(1,559)
Net loss$(13,179)$436 $(12,743)$(43,788)$5,292 $(38,496)
Net loss per share attributable to common stockholders—basic and diluted:
$(0.07)$— $(0.06)$(0.22)$— $(0.19)
Weighted-average shares used to compute net loss per share attributable to common stockholders—basic and diluted:
197,819 — 197,819 198,040 — 198,040 
The table below sets forth the unaudited condensed consolidated statements of comprehensive loss, including balances as reported, adjustments and balances as restated amounts (in thousands):
Three Months EndedSix Months Ended
June 30, 2022June 30, 2022
As ReportedAdjustmentsAs RestatedAs reportedAdjustmentsAs restated
Net Loss$(13,179)$436 $(12,743)$(43,788)$5,292 $(38,496)
Total other comprehensive income2,209 — 2,209 3,649 — 3,649 
Total comprehensive loss$(10,970)$436 $(10,534)$(40,139)$5,292 $(34,847)

The table below sets forth the unaudited condensed consolidated statements of stockholders’ equity, including balances as reported, adjustments and balances as restated amounts (in thousands):
Common StockAdditional
Paid-In
Capital
Accumulated
Deficit
Accumulated
Other
Comprehensive
Income
Total
Stockholders’
Equity
SharesAmount
Balance at June 30, 2022 as reported196,079 $196 $994,558 $(830,952)$1,854 $165,656 
Cumulative adjustments to net loss— — — 5,292 — 5,292 
Balance at June 30, 2022 as restated196,079 $196 $994,558 $(825,660)$1,854 $170,948 

The table below sets forth the unaudited condensed consolidated statement of cash flows, including balances as reported, adjustments and balances as restated amounts (in thousands):

Six Months Ended June 30, 2022
As ReportedAdjustmentsAs Restated
Cash flows from operating activities
Net loss
$(43,788)$5,292 $(38,496)
Adjustments to reconcile net loss to net cash provided by operating activities:
Depreciation and amortization
10,933 — 10,933 
Amortization of right-of-use assets852 — 852 
Amortization of debt issuance costs
112 — 112 
Impairment of other equity security170 — 170 
Stock-based compensation
44,712 — 44,712 
Deferred income taxes
1,955 (4,064)(2,109)
Change in fair value of contingent consideration(150)— (150)
Unrealized foreign exchange loss
3,405 — 3,405 
Other
(1)— (1)
Six Months Ended June 30, 2022
As ReportedAdjustmentsAs Restated
Changes in operating assets and liabilities, net of effects of business combination:
Accounts receivable
(2,357)— (2,357)
Prepaid expenses and other current assets
(417)— (417)
Other assets
(345)(338)
Accounts payable
(13,553)— (13,553)
Accrued expenses and other liabilities
8,156 (1,235)6,921 
Operating lease liabilities(1,642)— (1,642)
Income tax payable
15 — 15 
Deferred revenue
16,700 — 16,700 
Net cash provided by operating activities
24,757 — 24,757 
Cash flows from investing activities
Proceeds from acquisition working capital adjustment
307 — 307 
Purchase of property and equipment
(10,379)— (10,379)
Net cash used in investing activities
(10,072)— (10,072)
Cash flows from financing activities
Payment of contingent consideration(600)— (600)
Repurchase of common stock(39,155)— (39,155)
Shares surrendered for settlement of minimum statutory tax withholding
(30)— (30)
Proceeds from issuance of stock under employee stock plans1,487 — 1,487 
Net cash used in financing activities
(38,298)— (38,298)
Effect of exchange rate changes on cash and cash equivalents
(147)— (147)
Net decrease in cash and cash equivalents, and restricted cash equivalents
(23,760)— (23,760)
Cash and cash equivalents, and restricted cash equivalents, at beginning of the period
239,297 — 239,297 
Cash and cash equivalents at end of the period
$215,537 $— $215,537